KeyCorp director granted 7,352 deferred shares
Dallas H James reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Dallas H James reported acquisition or exercise transactions in this Form 4 filing.
KeyCorp director Dallas H. James reported a routine equity compensation grant. He received 7,352 Deferred Shares on Common Shares-equivalent terms under KeyCorp’s Amended and Restated Directors’ Deferred Share Sub-Plan of the KeyCorp 2026 Equity Compensation Plan.
Each Deferred Share is the economic equivalent of one Common Share. Under the plan, Mr. James will receive payment of these Deferred Shares one-half as Common Shares and one-half in cash on May 14, 2029. After these transactions, he holds 138,769 Common Shares directly and 26,777 Deferred Shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Shares | 7,352 | $0.00 | $0.00 |
| holding | Common Shares | -- | -- | -- |
Footnotes (3)
- F1. Each Deferred Share is the economic equivalent of one Common Share.
- F2. Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp 2026 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 14, 2029.
- F3. The Deferred Shares were awarded under the Deferred Share Plan.
Key Figures
Key Terms
KeyCorp 2026 Equity Compensation Plan financial
economic equivalent financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Dallas H. James report at KeyCorp (KEY)?
Is the KeyCorp (KEY) Form 4 transaction an open-market buy or sell?
AI-generated analysis. How Rhea-AI works. Not financial advice.